Literature DB >> 2856728

Atrial natriuretic factor stimulates renin release from the isolated rat kidney.

E Hackenthal1, R E Lang, C P Bührle.   

Abstract

Intrarenal infusion of atrial natriuretic factor has been reported to increase renal blood flow and sodium excretion, and either to depress or not to affect renin release. We examined the effect of a synthetic atrial peptide, AP II, on renin release, renal perfusate flow and glomerular filtration rate in isolated rat kidneys, perfused at constant pressure with a synthetic Krebs-Henseleit hydroxyethyl-starch-albumin medium. Atrial peptide II, 0.3 to 30 nmol/l, produced a concentration-dependent increase in renin release. Renal perfusate flow increased initially but returned to pre-infusion levels during infusion. During vasodilatation by continuous infusion of hydralazine, AP II produced only minor changes of perfusate flow but higher increases of renin release than in controls, indicating that this effect is not secondary to vasodilatation. During suppression of prostaglandin synthesis by indomethacin, the effects of AP II were unaltered. Furthermore, AP II in concentrations up to 200 nmol/l did not alter resting membrane potential in juxtaglomerular cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2856728

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  3 in total

1.  Involvement of endothelium-derived relaxing factor in the pressure control of renin secretion from isolated perfused kidney.

Authors:  H Scholz; A Kurtz
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

2.  Role of cGMP-kinase II in the control of renin secretion and renin expression.

Authors:  C Wagner; A Pfeifer; P Ruth; F Hofmann; A Kurtz
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

3.  Regulation of prorenin secretion in cultured human transfected juxtaglomerular cells.

Authors:  F Pinet; J Mizrahi; I Laboulandine; J Menard; P Corvol
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.